Carregant...
Phase II clinical trials on Investigational drugs for the Treatment of Pancreatic Cancers
INTRODUCTION: Despite some recent advances in treatment options, pancreatic cancer remains a devastating disease with poor outcomes. In a trend contrary to most malignancies, both incidence and mortality continue to rise due to pancreatic cancer. The majority of patients present with advanced diseas...
Guardat en:
| Publicat a: | Expert Opin Investig Drugs |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4684166/ https://ncbi.nlm.nih.gov/pubmed/25809274 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/13543784.2015.1026963 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|